<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nasdaq Trade System - Atara Biotherapeutics, Inc. - Common Stock</title>
    <!-- Latest compiled and minified CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/css/bootstrap.min.css" rel="stylesheet"
          integrity="sha384-4Q6Gf2aSP4eDXB8Miphtr37CMZZQ5oXLH2yaXMJ2w8e2ZtHTl7GptT4jmndRuHDT" crossorigin="anonymous">
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/js/bootstrap.bundle.min.js"
            integrity="sha384-j1CDi7MgGQ12Z7Qab0qlWQ/Qqz24Gc6BM0thvEMVjHnfYGF0rmFCozFSxQBxwHKO"
            crossorigin="anonymous"></script>
    <meta name="theme-color" content="#712cf9">
</head>

<body>
<header class="navbar sticky-top bg-dark flex-md-nowrap p-0 shadow" data-bs-theme="dark"><a
        class="navbar-brand col-md-3 col-lg-2 me-0 px-3 fs-6 text-white" href="#">Nasdaq Trade system</a>
</header>


<div class="container-fluid">
    <div class="row">

        <main class="col-md-9 ms-sm-auto col-lg-10 px-md-4">
            <a href="../GameResult.html">Back</a>
            <h1>Atara Biotherapeutics, Inc. - Common Stock</h1>
            <img src="ATRA.png" class="img-fluid">
            
            <div class="table-responsive small">
                <table class="table table-striped table-sm">
                    <thead>
                    <tr>
                        <th scope="col">ExecutedOn</th>
                        <th scope="col">Company</th>
                        <th scope="col">Listing</th>
                        <th scope="col">Amount</th>
                        <th scope="col">AtPrice</th>
                        <th scope="col">Total</th>
                    </tr>
                    </thead>
                    <tbody>
                    <tr scope="row">
                        <td>04-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>203</td>
                        <td>$491.00</td>
                        <td>$99,673.00</td>
                    </tr>
                    <tr scope="row">
                        <td>05-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-203</td>
                        <td>$481.50</td>
                        <td>-$97,744.50</td>
                    </tr>
                    <tr scope="row">
                        <td>05-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>203</td>
                        <td>$481.50</td>
                        <td>$97,744.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-203</td>
                        <td>$471.50</td>
                        <td>-$95,714.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>203</td>
                        <td>$471.50</td>
                        <td>$95,714.50</td>
                    </tr>
                    <tr scope="row">
                        <td>07-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-203</td>
                        <td>$502.25</td>
                        <td>-$101,956.75</td>
                    </tr>
                    <tr scope="row">
                        <td>07-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>203</td>
                        <td>$502.25</td>
                        <td>$101,956.75</td>
                    </tr>
                    <tr scope="row">
                        <td>08-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-203</td>
                        <td>$510.25</td>
                        <td>-$103,580.75</td>
                    </tr>
                    <tr scope="row">
                        <td>11-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>208</td>
                        <td>$497.38</td>
                        <td>$103,454.00</td>
                    </tr>
                    <tr scope="row">
                        <td>12-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-208</td>
                        <td>$495.50</td>
                        <td>-$103,064.00</td>
                    </tr>
                    <tr scope="row">
                        <td>12-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>208</td>
                        <td>$495.50</td>
                        <td>$103,064.00</td>
                    </tr>
                    <tr scope="row">
                        <td>13-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-208</td>
                        <td>$474.25</td>
                        <td>-$98,644.00</td>
                    </tr>
                    <tr scope="row">
                        <td>19-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>191</td>
                        <td>$475.50</td>
                        <td>$90,820.50</td>
                    </tr>
                    <tr scope="row">
                        <td>20-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-191</td>
                        <td>$456.75</td>
                        <td>-$87,239.25</td>
                    </tr>
                    <tr scope="row">
                        <td>08-02-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>154</td>
                        <td>$518.00</td>
                        <td>$79,772.00</td>
                    </tr>
                    <tr scope="row">
                        <td>09-02-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-154</td>
                        <td>$509.25</td>
                        <td>-$78,424.50</td>
                    </tr>
                    <tr scope="row">
                        <td>09-02-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>154</td>
                        <td>$509.25</td>
                        <td>$78,424.50</td>
                    </tr>
                    <tr scope="row">
                        <td>10-02-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-154</td>
                        <td>$484.00</td>
                        <td>-$74,536.00</td>
                    </tr>
                    <tr scope="row">
                        <td>02-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>156</td>
                        <td>$423.50</td>
                        <td>$66,066.00</td>
                    </tr>
                    <tr scope="row">
                        <td>03-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-156</td>
                        <td>$398.75</td>
                        <td>-$62,205.00</td>
                    </tr>
                    <tr scope="row">
                        <td>03-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>156</td>
                        <td>$398.75</td>
                        <td>$62,205.00</td>
                    </tr>
                    <tr scope="row">
                        <td>04-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-156</td>
                        <td>$397.25</td>
                        <td>-$61,971.00</td>
                    </tr>
                    <tr scope="row">
                        <td>04-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>156</td>
                        <td>$397.25</td>
                        <td>$61,971.00</td>
                    </tr>
                    <tr scope="row">
                        <td>05-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-156</td>
                        <td>$401.75</td>
                        <td>-$62,673.00</td>
                    </tr>
                    <tr scope="row">
                        <td>08-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>155</td>
                        <td>$404.50</td>
                        <td>$62,697.50</td>
                    </tr>
                    <tr scope="row">
                        <td>09-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-155</td>
                        <td>$413.50</td>
                        <td>-$64,092.50</td>
                    </tr>
                    <tr scope="row">
                        <td>09-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>155</td>
                        <td>$413.50</td>
                        <td>$64,092.50</td>
                    </tr>
                    <tr scope="row">
                        <td>10-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-155</td>
                        <td>$417.50</td>
                        <td>-$64,712.50</td>
                    </tr>
                    <tr scope="row">
                        <td>10-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>155</td>
                        <td>$417.50</td>
                        <td>$64,712.50</td>
                    </tr>
                    <tr scope="row">
                        <td>11-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-155</td>
                        <td>$424.88</td>
                        <td>-$65,855.63</td>
                    </tr>
                    <tr scope="row">
                        <td>11-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>155</td>
                        <td>$424.88</td>
                        <td>$65,855.63</td>
                    </tr>
                    <tr scope="row">
                        <td>12-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-155</td>
                        <td>$422.50</td>
                        <td>-$65,487.50</td>
                    </tr>
                    <tr scope="row">
                        <td>30-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>161</td>
                        <td>$355.50</td>
                        <td>$57,235.50</td>
                    </tr>
                    <tr scope="row">
                        <td>31-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-161</td>
                        <td>$359.00</td>
                        <td>-$57,799.00</td>
                    </tr>
                    <tr scope="row">
                        <td>07-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>146</td>
                        <td>$355.00</td>
                        <td>$51,830.00</td>
                    </tr>
                    <tr scope="row">
                        <td>08-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-146</td>
                        <td>$354.75</td>
                        <td>-$51,793.50</td>
                    </tr>
                    <tr scope="row">
                        <td>08-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>146</td>
                        <td>$354.75</td>
                        <td>$51,793.50</td>
                    </tr>
                    <tr scope="row">
                        <td>09-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-146</td>
                        <td>$344.25</td>
                        <td>-$50,260.50</td>
                    </tr>
                    <tr scope="row">
                        <td>12-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$342.50</td>
                        <td>$50,347.50</td>
                    </tr>
                    <tr scope="row">
                        <td>13-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$347.50</td>
                        <td>-$51,082.50</td>
                    </tr>
                    <tr scope="row">
                        <td>13-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$347.50</td>
                        <td>$51,082.50</td>
                    </tr>
                    <tr scope="row">
                        <td>14-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$346.25</td>
                        <td>-$50,898.75</td>
                    </tr>
                    <tr scope="row">
                        <td>14-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$346.25</td>
                        <td>$50,898.75</td>
                    </tr>
                    <tr scope="row">
                        <td>15-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$348.50</td>
                        <td>-$51,229.50</td>
                    </tr>
                    <tr scope="row">
                        <td>15-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$348.50</td>
                        <td>$51,229.50</td>
                    </tr>
                    <tr scope="row">
                        <td>16-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$332.00</td>
                        <td>-$48,804.00</td>
                    </tr>
                    <tr scope="row">
                        <td>19-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$332.50</td>
                        <td>$48,877.50</td>
                    </tr>
                    <tr scope="row">
                        <td>20-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$332.25</td>
                        <td>-$48,840.75</td>
                    </tr>
                    <tr scope="row">
                        <td>20-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$332.25</td>
                        <td>$48,840.75</td>
                    </tr>
                    <tr scope="row">
                        <td>21-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$341.00</td>
                        <td>-$50,127.00</td>
                    </tr>
                    <tr scope="row">
                        <td>21-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$341.00</td>
                        <td>$50,127.00</td>
                    </tr>
                    <tr scope="row">
                        <td>22-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$357.75</td>
                        <td>-$52,589.25</td>
                    </tr>
                    <tr scope="row">
                        <td>22-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>147</td>
                        <td>$357.75</td>
                        <td>$52,589.25</td>
                    </tr>
                    <tr scope="row">
                        <td>23-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-147</td>
                        <td>$353.50</td>
                        <td>-$51,964.50</td>
                    </tr>
                    <tr scope="row">
                        <td>27-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>133</td>
                        <td>$366.25</td>
                        <td>$48,711.25</td>
                    </tr>
                    <tr scope="row">
                        <td>28-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-133</td>
                        <td>$358.50</td>
                        <td>-$47,680.50</td>
                    </tr>
                    <tr scope="row">
                        <td>03-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>126</td>
                        <td>$351.25</td>
                        <td>$44,257.50</td>
                    </tr>
                    <tr scope="row">
                        <td>04-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-126</td>
                        <td>$341.25</td>
                        <td>-$42,997.50</td>
                    </tr>
                    <tr scope="row">
                        <td>04-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>126</td>
                        <td>$341.25</td>
                        <td>$42,997.50</td>
                    </tr>
                    <tr scope="row">
                        <td>05-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-126</td>
                        <td>$337.50</td>
                        <td>-$42,525.00</td>
                    </tr>
                    <tr scope="row">
                        <td>05-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>126</td>
                        <td>$337.50</td>
                        <td>$42,525.00</td>
                    </tr>
                    <tr scope="row">
                        <td>06-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-126</td>
                        <td>$322.25</td>
                        <td>-$40,603.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>126</td>
                        <td>$322.25</td>
                        <td>$40,603.50</td>
                    </tr>
                    <tr scope="row">
                        <td>07-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-126</td>
                        <td>$339.75</td>
                        <td>-$42,808.50</td>
                    </tr>
                    <tr scope="row">
                        <td>10-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>129</td>
                        <td>$331.00</td>
                        <td>$42,699.00</td>
                    </tr>
                    <tr scope="row">
                        <td>11-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-129</td>
                        <td>$347.75</td>
                        <td>-$44,859.75</td>
                    </tr>
                    <tr scope="row">
                        <td>11-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>129</td>
                        <td>$347.75</td>
                        <td>$44,859.75</td>
                    </tr>
                    <tr scope="row">
                        <td>12-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-129</td>
                        <td>$345.75</td>
                        <td>-$44,601.75</td>
                    </tr>
                    <tr scope="row">
                        <td>12-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>129</td>
                        <td>$345.75</td>
                        <td>$44,601.75</td>
                    </tr>
                    <tr scope="row">
                        <td>13-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-129</td>
                        <td>$368.00</td>
                        <td>-$47,472.00</td>
                    </tr>
                    <tr scope="row">
                        <td>13-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>129</td>
                        <td>$368.00</td>
                        <td>$47,472.00</td>
                    </tr>
                    <tr scope="row">
                        <td>14-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-129</td>
                        <td>$374.75</td>
                        <td>-$48,342.75</td>
                    </tr>
                    <tr scope="row">
                        <td>17-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>135</td>
                        <td>$359.25</td>
                        <td>$48,498.75</td>
                    </tr>
                    <tr scope="row">
                        <td>18-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-135</td>
                        <td>$363.25</td>
                        <td>-$49,038.75</td>
                    </tr>
                    <tr scope="row">
                        <td>18-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>135</td>
                        <td>$363.25</td>
                        <td>$49,038.75</td>
                    </tr>
                    <tr scope="row">
                        <td>19-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-135</td>
                        <td>$351.00</td>
                        <td>-$47,385.00</td>
                    </tr>
                    <tr scope="row">
                        <td>19-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>135</td>
                        <td>$351.00</td>
                        <td>$47,385.00</td>
                    </tr>
                    <tr scope="row">
                        <td>20-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-135</td>
                        <td>$358.75</td>
                        <td>-$48,431.25</td>
                    </tr>
                    <tr scope="row">
                        <td>20-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>135</td>
                        <td>$358.75</td>
                        <td>$48,431.25</td>
                    </tr>
                    <tr scope="row">
                        <td>21-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-135</td>
                        <td>$344.25</td>
                        <td>-$46,473.75</td>
                    </tr>
                    <tr scope="row">
                        <td>24-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>137</td>
                        <td>$339.75</td>
                        <td>$46,545.75</td>
                    </tr>
                    <tr scope="row">
                        <td>25-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-137</td>
                        <td>$330.75</td>
                        <td>-$45,312.75</td>
                    </tr>
                    <tr scope="row">
                        <td>25-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>137</td>
                        <td>$330.75</td>
                        <td>$45,312.75</td>
                    </tr>
                    <tr scope="row">
                        <td>26-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-137</td>
                        <td>$340.50</td>
                        <td>-$46,648.50</td>
                    </tr>
                    <tr scope="row">
                        <td>26-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>137</td>
                        <td>$340.50</td>
                        <td>$46,648.50</td>
                    </tr>
                    <tr scope="row">
                        <td>27-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-137</td>
                        <td>$342.00</td>
                        <td>-$46,854.00</td>
                    </tr>
                    <tr scope="row">
                        <td>27-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>137</td>
                        <td>$342.00</td>
                        <td>$46,854.00</td>
                    </tr>
                    <tr scope="row">
                        <td>28-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-137</td>
                        <td>$339.00</td>
                        <td>-$46,443.00</td>
                    </tr>
                    <tr scope="row">
                        <td>01-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>133</td>
                        <td>$349.25</td>
                        <td>$46,450.25</td>
                    </tr>
                    <tr scope="row">
                        <td>02-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-133</td>
                        <td>$345.75</td>
                        <td>-$45,984.75</td>
                    </tr>
                    <tr scope="row">
                        <td>10-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>124</td>
                        <td>$359.50</td>
                        <td>$44,578.00</td>
                    </tr>
                    <tr scope="row">
                        <td>11-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-124</td>
                        <td>$360.00</td>
                        <td>-$44,640.00</td>
                    </tr>
                    <tr scope="row">
                        <td>14-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>122</td>
                        <td>$366.50</td>
                        <td>$44,713.00</td>
                    </tr>
                    <tr scope="row">
                        <td>15-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-122</td>
                        <td>$350.00</td>
                        <td>-$42,700.00</td>
                    </tr>
                    <tr scope="row">
                        <td>16-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>112</td>
                        <td>$384.00</td>
                        <td>$43,008.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-112</td>
                        <td>$384.00</td>
                        <td>-$43,008.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>112</td>
                        <td>$384.00</td>
                        <td>$43,008.00</td>
                    </tr>
                    <tr scope="row">
                        <td>18-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-112</td>
                        <td>$375.25</td>
                        <td>-$42,028.00</td>
                    </tr>
                    <tr scope="row">
                        <td>21-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>107</td>
                        <td>$391.25</td>
                        <td>$41,863.75</td>
                    </tr>
                    <tr scope="row">
                        <td>22-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-107</td>
                        <td>$390.25</td>
                        <td>-$41,756.75</td>
                    </tr>
                    <tr scope="row">
                        <td>22-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>107</td>
                        <td>$390.25</td>
                        <td>$41,756.75</td>
                    </tr>
                    <tr scope="row">
                        <td>23-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-107</td>
                        <td>$387.50</td>
                        <td>-$41,462.50</td>
                    </tr>
                    <tr scope="row">
                        <td>23-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>107</td>
                        <td>$387.50</td>
                        <td>$41,462.50</td>
                    </tr>
                    <tr scope="row">
                        <td>24-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-107</td>
                        <td>$414.50</td>
                        <td>-$44,351.50</td>
                    </tr>
                    <tr scope="row">
                        <td>24-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>107</td>
                        <td>$414.50</td>
                        <td>$44,351.50</td>
                    </tr>
                    <tr scope="row">
                        <td>25-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-107</td>
                        <td>$408.75</td>
                        <td>-$43,736.25</td>
                    </tr>
                    <tr scope="row">
                        <td>28-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>109</td>
                        <td>$401.00</td>
                        <td>$43,709.00</td>
                    </tr>
                    <tr scope="row">
                        <td>29-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-109</td>
                        <td>$388.50</td>
                        <td>-$42,346.50</td>
                    </tr>
                    <tr scope="row">
                        <td>29-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>109</td>
                        <td>$388.50</td>
                        <td>$42,346.50</td>
                    </tr>
                    <tr scope="row">
                        <td>30-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-109</td>
                        <td>$388.75</td>
                        <td>-$42,373.75</td>
                    </tr>
                    <tr scope="row">
                        <td>30-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>109</td>
                        <td>$388.75</td>
                        <td>$42,373.75</td>
                    </tr>
                    <tr scope="row">
                        <td>01-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-109</td>
                        <td>$401.25</td>
                        <td>-$43,736.25</td>
                    </tr>
                    <tr scope="row">
                        <td>01-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>109</td>
                        <td>$401.25</td>
                        <td>$43,736.25</td>
                    </tr>
                    <tr scope="row">
                        <td>02-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-109</td>
                        <td>$398.00</td>
                        <td>-$43,382.00</td>
                    </tr>
                    <tr scope="row">
                        <td>06-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>119</td>
                        <td>$364.00</td>
                        <td>$43,316.00</td>
                    </tr>
                    <tr scope="row">
                        <td>07-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-119</td>
                        <td>$364.75</td>
                        <td>-$43,405.25</td>
                    </tr>
                    <tr scope="row">
                        <td>07-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>119</td>
                        <td>$364.75</td>
                        <td>$43,405.25</td>
                    </tr>
                    <tr scope="row">
                        <td>08-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-119</td>
                        <td>$362.75</td>
                        <td>-$43,167.25</td>
                    </tr>
                    <tr scope="row">
                        <td>08-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>119</td>
                        <td>$362.75</td>
                        <td>$43,167.25</td>
                    </tr>
                    <tr scope="row">
                        <td>09-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-119</td>
                        <td>$353.75</td>
                        <td>-$42,096.25</td>
                    </tr>
                    <tr scope="row">
                        <td>01-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$392.25</td>
                        <td>$34,910.25</td>
                    </tr>
                    <tr scope="row">
                        <td>02-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$403.00</td>
                        <td>-$35,867.00</td>
                    </tr>
                    <tr scope="row">
                        <td>02-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$403.00</td>
                        <td>$35,867.00</td>
                    </tr>
                    <tr scope="row">
                        <td>03-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$389.00</td>
                        <td>-$34,621.00</td>
                    </tr>
                    <tr scope="row">
                        <td>27-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>85</td>
                        <td>$436.75</td>
                        <td>$37,123.75</td>
                    </tr>
                    <tr scope="row">
                        <td>28-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-85</td>
                        <td>$434.75</td>
                        <td>-$36,953.75</td>
                    </tr>
                    <tr scope="row">
                        <td>28-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>85</td>
                        <td>$434.75</td>
                        <td>$36,953.75</td>
                    </tr>
                    <tr scope="row">
                        <td>29-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-85</td>
                        <td>$438.75</td>
                        <td>-$37,293.75</td>
                    </tr>
                    <tr scope="row">
                        <td>29-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>85</td>
                        <td>$438.75</td>
                        <td>$37,293.75</td>
                    </tr>
                    <tr scope="row">
                        <td>30-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-85</td>
                        <td>$447.50</td>
                        <td>-$38,037.50</td>
                    </tr>
                    <tr scope="row">
                        <td>30-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>85</td>
                        <td>$447.50</td>
                        <td>$38,037.50</td>
                    </tr>
                    <tr scope="row">
                        <td>01-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-85</td>
                        <td>$437.50</td>
                        <td>-$37,187.50</td>
                    </tr>
                    <tr scope="row">
                        <td>04-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$436.25</td>
                        <td>$37,517.50</td>
                    </tr>
                    <tr scope="row">
                        <td>05-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$437.00</td>
                        <td>-$37,582.00</td>
                    </tr>
                    <tr scope="row">
                        <td>05-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$437.00</td>
                        <td>$37,582.00</td>
                    </tr>
                    <tr scope="row">
                        <td>06-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$435.25</td>
                        <td>-$37,431.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$435.25</td>
                        <td>$37,431.50</td>
                    </tr>
                    <tr scope="row">
                        <td>07-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$440.50</td>
                        <td>-$37,883.00</td>
                    </tr>
                    <tr scope="row">
                        <td>07-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$440.50</td>
                        <td>$37,883.00</td>
                    </tr>
                    <tr scope="row">
                        <td>08-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$426.25</td>
                        <td>-$36,657.50</td>
                    </tr>
                    <tr scope="row">
                        <td>12-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>81</td>
                        <td>$449.50</td>
                        <td>$36,409.50</td>
                    </tr>
                    <tr scope="row">
                        <td>13-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-81</td>
                        <td>$391.50</td>
                        <td>-$31,711.50</td>
                    </tr>
                    <tr scope="row">
                        <td>13-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>81</td>
                        <td>$391.50</td>
                        <td>$31,711.50</td>
                    </tr>
                    <tr scope="row">
                        <td>14-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-81</td>
                        <td>$394.00</td>
                        <td>-$31,914.00</td>
                    </tr>
                    <tr scope="row">
                        <td>14-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>81</td>
                        <td>$394.00</td>
                        <td>$31,914.00</td>
                    </tr>
                    <tr scope="row">
                        <td>15-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-81</td>
                        <td>$378.00</td>
                        <td>-$30,618.00</td>
                    </tr>
                    <tr scope="row">
                        <td>18-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>84</td>
                        <td>$367.50</td>
                        <td>$30,870.00</td>
                    </tr>
                    <tr scope="row">
                        <td>19-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-84</td>
                        <td>$378.25</td>
                        <td>-$31,773.00</td>
                    </tr>
                    <tr scope="row">
                        <td>19-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>84</td>
                        <td>$378.25</td>
                        <td>$31,773.00</td>
                    </tr>
                    <tr scope="row">
                        <td>20-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-84</td>
                        <td>$392.75</td>
                        <td>-$32,991.00</td>
                    </tr>
                    <tr scope="row">
                        <td>20-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>84</td>
                        <td>$392.75</td>
                        <td>$32,991.00</td>
                    </tr>
                    <tr scope="row">
                        <td>21-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-84</td>
                        <td>$395.25</td>
                        <td>-$33,201.00</td>
                    </tr>
                    <tr scope="row">
                        <td>21-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>84</td>
                        <td>$395.25</td>
                        <td>$33,201.00</td>
                    </tr>
                    <tr scope="row">
                        <td>22-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-84</td>
                        <td>$400.75</td>
                        <td>-$33,663.00</td>
                    </tr>
                    <tr scope="row">
                        <td>25-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$379.50</td>
                        <td>$33,396.00</td>
                    </tr>
                    <tr scope="row">
                        <td>26-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$380.00</td>
                        <td>-$33,440.00</td>
                    </tr>
                    <tr scope="row">
                        <td>26-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$380.00</td>
                        <td>$33,440.00</td>
                    </tr>
                    <tr scope="row">
                        <td>27-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$374.50</td>
                        <td>-$32,956.00</td>
                    </tr>
                    <tr scope="row">
                        <td>27-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$374.50</td>
                        <td>$32,956.00</td>
                    </tr>
                    <tr scope="row">
                        <td>28-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$391.00</td>
                        <td>-$34,408.00</td>
                    </tr>
                    <tr scope="row">
                        <td>28-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$391.00</td>
                        <td>$34,408.00</td>
                    </tr>
                    <tr scope="row">
                        <td>29-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$387.00</td>
                        <td>-$34,056.00</td>
                    </tr>
                    <tr scope="row">
                        <td>01-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>83</td>
                        <td>$412.75</td>
                        <td>$34,258.25</td>
                    </tr>
                    <tr scope="row">
                        <td>02-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-83</td>
                        <td>$434.00</td>
                        <td>-$36,022.00</td>
                    </tr>
                    <tr scope="row">
                        <td>02-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>83</td>
                        <td>$434.00</td>
                        <td>$36,022.00</td>
                    </tr>
                    <tr scope="row">
                        <td>03-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-83</td>
                        <td>$468.75</td>
                        <td>-$38,906.25</td>
                    </tr>
                    <tr scope="row">
                        <td>03-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>83</td>
                        <td>$468.75</td>
                        <td>$38,906.25</td>
                    </tr>
                    <tr scope="row">
                        <td>04-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-83</td>
                        <td>$497.25</td>
                        <td>-$41,271.75</td>
                    </tr>
                    <tr scope="row">
                        <td>04-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>83</td>
                        <td>$497.25</td>
                        <td>$41,271.75</td>
                    </tr>
                    <tr scope="row">
                        <td>05-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-83</td>
                        <td>$454.25</td>
                        <td>-$37,702.75</td>
                    </tr>
                    <tr scope="row">
                        <td>08-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>85</td>
                        <td>$441.00</td>
                        <td>$37,485.00</td>
                    </tr>
                    <tr scope="row">
                        <td>09-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-85</td>
                        <td>$448.25</td>
                        <td>-$38,101.25</td>
                    </tr>
                    <tr scope="row">
                        <td>09-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>85</td>
                        <td>$448.25</td>
                        <td>$38,101.25</td>
                    </tr>
                    <tr scope="row">
                        <td>10-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-85</td>
                        <td>$432.50</td>
                        <td>-$36,762.50</td>
                    </tr>
                    <tr scope="row">
                        <td>10-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>85</td>
                        <td>$432.50</td>
                        <td>$36,762.50</td>
                    </tr>
                    <tr scope="row">
                        <td>12-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-85</td>
                        <td>$440.50</td>
                        <td>-$37,442.50</td>
                    </tr>
                    <tr scope="row">
                        <td>15-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$426.75</td>
                        <td>$37,554.00</td>
                    </tr>
                    <tr scope="row">
                        <td>16-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$434.25</td>
                        <td>-$38,214.00</td>
                    </tr>
                    <tr scope="row">
                        <td>16-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$434.25</td>
                        <td>$38,214.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$445.00</td>
                        <td>-$39,160.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$445.00</td>
                        <td>$39,160.00</td>
                    </tr>
                    <tr scope="row">
                        <td>18-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$445.75</td>
                        <td>-$39,226.00</td>
                    </tr>
                    <tr scope="row">
                        <td>18-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$445.75</td>
                        <td>$39,226.00</td>
                    </tr>
                    <tr scope="row">
                        <td>19-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$457.50</td>
                        <td>-$40,260.00</td>
                    </tr>
                    <tr scope="row">
                        <td>22-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$454.75</td>
                        <td>$40,472.75</td>
                    </tr>
                    <tr scope="row">
                        <td>23-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$451.75</td>
                        <td>-$40,205.75</td>
                    </tr>
                    <tr scope="row">
                        <td>23-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$451.75</td>
                        <td>$40,205.75</td>
                    </tr>
                    <tr scope="row">
                        <td>24-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$453.75</td>
                        <td>-$40,383.75</td>
                    </tr>
                    <tr scope="row">
                        <td>29-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$444.75</td>
                        <td>$40,027.50</td>
                    </tr>
                    <tr scope="row">
                        <td>30-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$447.25</td>
                        <td>-$40,252.50</td>
                    </tr>
                    <tr scope="row">
                        <td>30-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$447.25</td>
                        <td>$40,252.50</td>
                    </tr>
                    <tr scope="row">
                        <td>01-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$434.00</td>
                        <td>-$39,060.00</td>
                    </tr>
                    <tr scope="row">
                        <td>01-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$434.00</td>
                        <td>$39,060.00</td>
                    </tr>
                    <tr scope="row">
                        <td>02-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$450.25</td>
                        <td>-$40,522.50</td>
                    </tr>
                    <tr scope="row">
                        <td>02-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$450.25</td>
                        <td>$40,522.50</td>
                    </tr>
                    <tr scope="row">
                        <td>03-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$427.25</td>
                        <td>-$38,452.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$424.50</td>
                        <td>$38,629.50</td>
                    </tr>
                    <tr scope="row">
                        <td>07-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$447.25</td>
                        <td>-$40,699.75</td>
                    </tr>
                    <tr scope="row">
                        <td>07-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$447.25</td>
                        <td>$40,699.75</td>
                    </tr>
                    <tr scope="row">
                        <td>08-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$438.00</td>
                        <td>-$39,858.00</td>
                    </tr>
                    <tr scope="row">
                        <td>08-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$438.00</td>
                        <td>$39,858.00</td>
                    </tr>
                    <tr scope="row">
                        <td>09-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$407.75</td>
                        <td>-$37,105.25</td>
                    </tr>
                    <tr scope="row">
                        <td>09-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$407.75</td>
                        <td>$37,105.25</td>
                    </tr>
                    <tr scope="row">
                        <td>10-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$399.50</td>
                        <td>-$36,354.50</td>
                    </tr>
                    <tr scope="row">
                        <td>13-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>93</td>
                        <td>$391.50</td>
                        <td>$36,409.50</td>
                    </tr>
                    <tr scope="row">
                        <td>14-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-93</td>
                        <td>$392.75</td>
                        <td>-$36,525.75</td>
                    </tr>
                    <tr scope="row">
                        <td>14-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>93</td>
                        <td>$392.75</td>
                        <td>$36,525.75</td>
                    </tr>
                    <tr scope="row">
                        <td>15-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-93</td>
                        <td>$400.75</td>
                        <td>-$37,269.75</td>
                    </tr>
                    <tr scope="row">
                        <td>15-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>93</td>
                        <td>$400.75</td>
                        <td>$37,269.75</td>
                    </tr>
                    <tr scope="row">
                        <td>16-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-93</td>
                        <td>$381.75</td>
                        <td>-$35,502.75</td>
                    </tr>
                    <tr scope="row">
                        <td>16-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>93</td>
                        <td>$381.75</td>
                        <td>$35,502.75</td>
                    </tr>
                    <tr scope="row">
                        <td>17-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-93</td>
                        <td>$378.75</td>
                        <td>-$35,223.75</td>
                    </tr>
                    <tr scope="row">
                        <td>20-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$392.25</td>
                        <td>$35,302.50</td>
                    </tr>
                    <tr scope="row">
                        <td>21-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$389.00</td>
                        <td>-$35,010.00</td>
                    </tr>
                    <tr scope="row">
                        <td>21-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$389.00</td>
                        <td>$35,010.00</td>
                    </tr>
                    <tr scope="row">
                        <td>22-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$408.75</td>
                        <td>-$36,787.50</td>
                    </tr>
                    <tr scope="row">
                        <td>22-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$408.75</td>
                        <td>$36,787.50</td>
                    </tr>
                    <tr scope="row">
                        <td>23-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$432.75</td>
                        <td>-$38,947.50</td>
                    </tr>
                    <tr scope="row">
                        <td>27-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$428.25</td>
                        <td>$38,970.75</td>
                    </tr>
                    <tr scope="row">
                        <td>28-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$431.00</td>
                        <td>-$39,221.00</td>
                    </tr>
                    <tr scope="row">
                        <td>28-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$431.00</td>
                        <td>$39,221.00</td>
                    </tr>
                    <tr scope="row">
                        <td>29-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$426.00</td>
                        <td>-$38,766.00</td>
                    </tr>
                    <tr scope="row">
                        <td>29-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$426.00</td>
                        <td>$38,766.00</td>
                    </tr>
                    <tr scope="row">
                        <td>30-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$403.00</td>
                        <td>-$36,673.00</td>
                    </tr>
                    <tr scope="row">
                        <td>30-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$403.00</td>
                        <td>$36,673.00</td>
                    </tr>
                    <tr scope="row">
                        <td>03-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$422.25</td>
                        <td>-$38,424.75</td>
                    </tr>
                    <tr scope="row">
                        <td>03-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$422.25</td>
                        <td>$38,424.75</td>
                    </tr>
                    <tr scope="row">
                        <td>04-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$406.75</td>
                        <td>-$37,014.25</td>
                    </tr>
                    <tr scope="row">
                        <td>04-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$406.75</td>
                        <td>$37,014.25</td>
                    </tr>
                    <tr scope="row">
                        <td>05-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$389.50</td>
                        <td>-$35,444.50</td>
                    </tr>
                    <tr scope="row">
                        <td>05-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$389.50</td>
                        <td>$35,444.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$399.50</td>
                        <td>-$36,354.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>91</td>
                        <td>$399.50</td>
                        <td>$36,354.50</td>
                    </tr>
                    <tr scope="row">
                        <td>07-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-91</td>
                        <td>$392.75</td>
                        <td>-$35,740.25</td>
                    </tr>
                    <tr scope="row">
                        <td>10-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$397.00</td>
                        <td>$35,730.00</td>
                    </tr>
                    <tr scope="row">
                        <td>11-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$386.00</td>
                        <td>-$34,740.00</td>
                    </tr>
                    <tr scope="row">
                        <td>11-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$386.00</td>
                        <td>$34,740.00</td>
                    </tr>
                    <tr scope="row">
                        <td>12-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$359.75</td>
                        <td>-$32,377.50</td>
                    </tr>
                    <tr scope="row">
                        <td>12-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$359.75</td>
                        <td>$32,377.50</td>
                    </tr>
                    <tr scope="row">
                        <td>13-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$355.75</td>
                        <td>-$32,017.50</td>
                    </tr>
                    <tr scope="row">
                        <td>13-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>90</td>
                        <td>$355.75</td>
                        <td>$32,017.50</td>
                    </tr>
                    <tr scope="row">
                        <td>14-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-90</td>
                        <td>$401.75</td>
                        <td>-$36,157.50</td>
                    </tr>
                    <tr scope="row">
                        <td>18-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>97</td>
                        <td>$372.75</td>
                        <td>$36,156.75</td>
                    </tr>
                    <tr scope="row">
                        <td>19-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-97</td>
                        <td>$380.50</td>
                        <td>-$36,908.50</td>
                    </tr>
                    <tr scope="row">
                        <td>19-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>97</td>
                        <td>$380.50</td>
                        <td>$36,908.50</td>
                    </tr>
                    <tr scope="row">
                        <td>20-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-97</td>
                        <td>$357.75</td>
                        <td>-$34,701.75</td>
                    </tr>
                    <tr scope="row">
                        <td>20-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>97</td>
                        <td>$357.75</td>
                        <td>$34,701.75</td>
                    </tr>
                    <tr scope="row">
                        <td>21-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-97</td>
                        <td>$349.75</td>
                        <td>-$33,925.75</td>
                    </tr>
                    <tr scope="row">
                        <td>24-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>92</td>
                        <td>$366.50</td>
                        <td>$33,718.00</td>
                    </tr>
                    <tr scope="row">
                        <td>25-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-92</td>
                        <td>$377.50</td>
                        <td>-$34,730.00</td>
                    </tr>
                    <tr scope="row">
                        <td>25-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>92</td>
                        <td>$377.50</td>
                        <td>$34,730.00</td>
                    </tr>
                    <tr scope="row">
                        <td>26-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-92</td>
                        <td>$381.25</td>
                        <td>-$35,075.00</td>
                    </tr>
                    <tr scope="row">
                        <td>26-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>92</td>
                        <td>$381.25</td>
                        <td>$35,075.00</td>
                    </tr>
                    <tr scope="row">
                        <td>27-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-92</td>
                        <td>$356.50</td>
                        <td>-$32,798.00</td>
                    </tr>
                    <tr scope="row">
                        <td>27-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>92</td>
                        <td>$356.50</td>
                        <td>$32,798.00</td>
                    </tr>
                    <tr scope="row">
                        <td>28-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-92</td>
                        <td>$371.50</td>
                        <td>-$34,178.00</td>
                    </tr>
                    <tr scope="row">
                        <td>31-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$384.00</td>
                        <td>$34,176.00</td>
                    </tr>
                    <tr scope="row">
                        <td>01-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$386.75</td>
                        <td>-$34,420.75</td>
                    </tr>
                    <tr scope="row">
                        <td>01-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$386.75</td>
                        <td>$34,420.75</td>
                    </tr>
                    <tr scope="row">
                        <td>02-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$368.75</td>
                        <td>-$32,818.75</td>
                    </tr>
                    <tr scope="row">
                        <td>02-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$368.75</td>
                        <td>$32,818.75</td>
                    </tr>
                    <tr scope="row">
                        <td>03-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$368.75</td>
                        <td>-$32,818.75</td>
                    </tr>
                    <tr scope="row">
                        <td>03-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$368.75</td>
                        <td>$32,818.75</td>
                    </tr>
                    <tr scope="row">
                        <td>04-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$365.25</td>
                        <td>-$32,507.25</td>
                    </tr>
                    <tr scope="row">
                        <td>07-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$380.00</td>
                        <td>$32,680.00</td>
                    </tr>
                    <tr scope="row">
                        <td>08-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$380.50</td>
                        <td>-$32,723.00</td>
                    </tr>
                    <tr scope="row">
                        <td>08-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$380.50</td>
                        <td>$32,723.00</td>
                    </tr>
                    <tr scope="row">
                        <td>09-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$393.25</td>
                        <td>-$33,819.50</td>
                    </tr>
                    <tr scope="row">
                        <td>09-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$393.25</td>
                        <td>$33,819.50</td>
                    </tr>
                    <tr scope="row">
                        <td>10-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$375.25</td>
                        <td>-$32,271.50</td>
                    </tr>
                    <tr scope="row">
                        <td>10-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>86</td>
                        <td>$375.25</td>
                        <td>$32,271.50</td>
                    </tr>
                    <tr scope="row">
                        <td>11-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-86</td>
                        <td>$364.00</td>
                        <td>-$31,304.00</td>
                    </tr>
                    <tr scope="row">
                        <td>14-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$356.00</td>
                        <td>$31,328.00</td>
                    </tr>
                    <tr scope="row">
                        <td>15-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$374.25</td>
                        <td>-$32,934.00</td>
                    </tr>
                    <tr scope="row">
                        <td>15-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$374.25</td>
                        <td>$32,934.00</td>
                    </tr>
                    <tr scope="row">
                        <td>16-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$368.50</td>
                        <td>-$32,428.00</td>
                    </tr>
                    <tr scope="row">
                        <td>16-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$368.50</td>
                        <td>$32,428.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$342.00</td>
                        <td>-$30,096.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>88</td>
                        <td>$342.00</td>
                        <td>$30,096.00</td>
                    </tr>
                    <tr scope="row">
                        <td>18-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-88</td>
                        <td>$328.00</td>
                        <td>-$28,864.00</td>
                    </tr>
                    <tr scope="row">
                        <td>22-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>87</td>
                        <td>$330.50</td>
                        <td>$28,753.50</td>
                    </tr>
                    <tr scope="row">
                        <td>23-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-87</td>
                        <td>$319.00</td>
                        <td>-$27,753.00</td>
                    </tr>
                    <tr scope="row">
                        <td>23-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>87</td>
                        <td>$319.00</td>
                        <td>$27,753.00</td>
                    </tr>
                    <tr scope="row">
                        <td>24-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-87</td>
                        <td>$330.50</td>
                        <td>-$28,753.50</td>
                    </tr>
                    <tr scope="row">
                        <td>24-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>87</td>
                        <td>$330.50</td>
                        <td>$28,753.50</td>
                    </tr>
                    <tr scope="row">
                        <td>25-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-87</td>
                        <td>$329.75</td>
                        <td>-$28,688.25</td>
                    </tr>
                    <tr scope="row">
                        <td>28-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>89</td>
                        <td>$321.25</td>
                        <td>$28,591.25</td>
                    </tr>
                    <tr scope="row">
                        <td>01-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-89</td>
                        <td>$255.25</td>
                        <td>-$22,717.25</td>
                    </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>
</div>
</body>
</html>